Lifeboat Foundation

Imagine working in the hot streets of Manila in the early 1990s. You are a butcher, slaving away in a loud, humid market for long hours. You only make several dollars a day to support a large family.

One evening, you are holding a Pepsi bottle cap in your hand. On it is a number. You bought several of these sodas in hopes of winning a big $40,000 giveaway at the end of the promotion. This money could change your family’s life. It is a mountain of earnings in a world of limited opportunities. You watch as Pepsi begins reading off the winners on TV.

Suddenly, you realize you’ve won. Incredulous, you quadruple check your numbers. The number is accurate. Your heart begins racing as you rush to call your wife and kids. However, you, and many winners like you, will never see that money. But at least you won’t lose your life, like some.

It’s the second time Kathy Sullivan has made history, this time with @EYOSExpeditions. #NASA

Guessing things are about to get dicey.

Texas reported a record-breaking number of COVID-19 hospitalizations Monday as the governor plans to reopen more businesses and double capacity.

Texas Department of State Health Services figures show 1,935 people were admitted as hospital patients for coronavirus-related treatment. That is up from a previous record of 1,888 on May 5.

Continue reading “Texas Reports Record-Breaking COVID-19 Hospitalizations As State Reopens” »

Type: Novel lipid nanoparticle (LNP)-encapsulated mRNA vaccine encoding for a prefusion stabilized form of the Spike (S) protein.

Status: Moderna said May 29 the first patients in both cohorts were dosed in the company’s Phase II trial (NCT04405076) assessing mRNA-1273. The study is designed to evaluate the safety, reactogenicity and immunogenicity of two vaccinations of mRNA-1273, given 28 days apart. plans to enroll 600 healthy participants across two cohorts: 300 adults ages 18–55 years, and 300 ages 55 years and up. Participants will be assigned to placebo, a 50 μg or a 100 μg dose at both vaccinations, and will be followed through 12 months after the second vaccination.

Pharmaceutical companies use the creature’s blue blood to test for contaminants.

Every year, more than 400,000 crabs are bled for the miraculous medical substance that flows through their bodies—now pharmaceutical companies are finally committing to an alternative that doesn’t harm animals.

A laser pulse, a special material, an extraordinary property which appears inexplicably. These are the main elements that emerge from a research conducted by an international team, coordinated by Michele Fabrizio and comprising Andrea Nava and Erio Tosatti from SISSA, Claudio Giannetti from the Università Cattolica di Brescia and Antoine Georges from the Collège de France. The results of their study have recently been published in the journal Nature Physics. The key element of the study is a compound of the most symmetrical molecule that exists in Nature, namely C60 bucky-ball, a spherical fullerene.

It is well known that this compound, with the chemical formula K3C60, can behave as a superconductor — that is, conduct without dissipating energy — below a critical temperature of 20 degrees Kelvin, i.e. around −253 degrees Celsius.

It has recently been discovered that K3C60 is capable of transforming into a high-temperature superconductor when struck by an extremely brief laser pulse. This material takes on superconductive properties — albeit extremely briefly — up to a temperature of −73 degrees Centigrade, almost 100 degrees above the critical equilibrium temperature. The research just published by the scientists explains the reason for this mysterious behaviour.

Experts wonder how genetic engineering will eventually reshape the natural world.

After her dive yesterday, Dr. Kathy Sullivan spoke to astronauts on the International Space Station to compare notes about “recyclable” vessels for undersea and space exploration.